Drugs / formyltetrahydrofolate
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05978349 | Feb 2022 → Sep 2025 | colorectal cancer | Peking Union Medical College Hospital | Unknown | No outcome recorded |
| — | NCT05424692 | Sep 2021 → Sep 2025 overdue | chemotherapy-induced toxicity, colon carcinoma, rectal carcinoma | Peking Union Medical College Hospital | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | formyltetrahydrofolate | “Choose chemotherapeutic drugs（5-fluorouracil + formyltetrahydrofolate/Oxaliplatin + 5-fluorouracil + formyltetrahydrofolate/Irinotecan + 5-fluorouracil +...” NCT05978349 ↗ |